LOGIN
Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis
February 2022
Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial.
J Foot Ankle Surg . Jan-Feb 2022;61(1):48-52.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Twenty nine patients with chronic plantar fasciitis were randomized to receive extracorporeal shockwave therapy (ESWT, n=15) or dextrose prolotherapy (n=15). Outcomes of interest included pain measured using a visual analogue scale (VAS) and function measured with the Roles and Maudsley Scale score (RMS) and the Foot Function Index (FFI). Both groups demonstrated significant improvements in pain a...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.